{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:15:36Z","timestamp":1788992136286,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T00:00:00Z","timestamp":1537488000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00701-018-3680-z","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T01:27:11Z","timestamp":1537493231000},"page":"2099-2105","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Intrathecal penetration of meropenem and vancomycin administered by continuous infusion in patients suffering from ventriculitis\u2014a retrospective analysis"],"prefix":"10.1007","volume":"160","author":[{"given":"Marius Marc-Daniel","family":"Mader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Czorlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Fuhrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kluge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3341-669X","authenticated-orcid":false,"given":"J\u00f6rn","family":"Grensemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,21]]},"reference":[{"key":"3680_CR1","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1128\/AAC.44.5.1356-1358.2000","volume":"44","author":"J Albanese","year":"2000","unstructured":"Albanese J, Leone M, Bruguerolle B, Ayem ML, Lacarelle B, Martin C (2000) Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit. Antimicrob Agents Chemother 44:1356\u20131358","journal-title":"Antimicrob Agents Chemother"},{"key":"3680_CR2","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s40262-017-0548-y","volume":"56","author":"JE Beach","year":"2017","unstructured":"Beach JE, Perrott J, Turgeon RD, Ensom MHH (2017) Penetration of vancomycin into the cerebrospinal fluid: a systematic review. Clin Pharmacokinet 56:1479\u20131490. \n                    https:\/\/doi.org\/10.1007\/s40262-017-0548-y","journal-title":"Clin Pharmacokinet"},{"key":"3680_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s13054-016-1523-y","volume":"20","author":"U Blassmann","year":"2016","unstructured":"Blassmann U, Roehr AC, Frey OR, Vetter-Kerkhoff C, Thon N, Hope W, Briegel J, Huge V (2016) Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study. Crit Care 20:343. \n                    https:\/\/doi.org\/10.1186\/s13054-016-1523-y","journal-title":"Crit Care"},{"key":"3680_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/jac\/dkr442","volume":"67","author":"MA Cataldo","year":"2012","unstructured":"Cataldo MA, Tacconelli E, Grilli E, Pea F, Petrosillo N (2012) Continuous versus intermittent infusion of vancomycin for the treatment of gram-positive infections: systematic review and meta-analysis. J Antimicrob Chemother 67:17\u201324. \n                    https:\/\/doi.org\/10.1093\/jac\/dkr442","journal-title":"J Antimicrob Chemother"},{"key":"3680_CR5","unstructured":"CDC\/NHSN (2018) CDC\/NHSN surveillance definitions for specific types of infections. \n                    https:\/\/www.cdc.gov\/nhsn\/PDFs\/pscManual\/17pscNosInfDef_current.pdf\n                    \n                  . Accessed August 3, 2018"},{"key":"3680_CR6","doi-asserted-by":"publisher","first-page":"218.e211","DOI":"10.1016\/j.jcrc.2014.09.020","volume":"30","author":"K Chen","year":"2015","unstructured":"Chen K, Wu Y, Wang Q, Wang J, Li X, Zhao Z, Zhou J (2015) The methodology and pharmacokinetics study of intraventricular administration of vancomycin in patients with intracranial infections after craniotomy. J Crit Care 30:218.e211\u2013218.e215. \n                    https:\/\/doi.org\/10.1016\/j.jcrc.2014.09.020","journal-title":"J Crit Care"},{"key":"3680_CR7","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1164\/rccm.201505-0857OC","volume":"192","author":"JM Dulhunty","year":"2015","unstructured":"Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Starr T, Paul SK, Lipman J (2015) A multicenter randomized trial of continuous versus intermittent beta-lactam infusion in severe sepsis. Am J Respir Crit Care Med 192:1298\u20131305. \n                    https:\/\/doi.org\/10.1164\/rccm.201505-0857OC","journal-title":"Am J Respir Crit Care Med"},{"key":"3680_CR8","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"JR Gall Le","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European\/North American multicenter study. JAMA 270:2957\u20132963","journal-title":"JAMA"},{"key":"3680_CR9","first-page":"404","volume":"70","author":"T Ichie","year":"2015","unstructured":"Ichie T, Urano K, Suzuki D, Okada T, Kobayashi N, Hayashi H, Sugiura Y, Yamamura K, Sugiyama T (2015) Influence of cerebral fluid drainage on the pharmacokinetics of vancomycin in neurosurgical patients. Pharmazie 70:404\u2013409","journal-title":"Pharmazie"},{"key":"3680_CR10","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0140-6736(75)92830-5","volume":"1","author":"B Jennett","year":"1975","unstructured":"Jennett B, Bond M (1975) Assessment of outcome after severe brain damage. Lancet 1:480\u2013484","journal-title":"Lancet"},{"key":"3680_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"3680_CR12","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1128\/aac.00294-06","volume":"51","author":"C Li","year":"2007","unstructured":"Li C, Du X, Kuti JL, Nicolau DP (2007) Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections. Antimicrob Agents Chemother 51:1725\u20131730. \n                    https:\/\/doi.org\/10.1128\/aac.00294-06","journal-title":"Antimicrob Agents Chemother"},{"key":"3680_CR13","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/ftd.0000000000000187","volume":"37","author":"FL Lin Wu","year":"2015","unstructured":"Lin Wu FL, Liu SS, Yang TY, Win MF, Lin SW, Huang CF, Wang KC, Shen LJ (2015) A larger dose of vancomycin is required in adult neurosurgical intensive care unit patients due to augmented clearance. Ther Drug Monit 37:609\u2013618. \n                    https:\/\/doi.org\/10.1097\/ftd.0000000000000187","journal-title":"Ther Drug Monit"},{"key":"3680_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3171\/2012.10.Jns12883","volume":"118","author":"DO Lonsdale","year":"2013","unstructured":"Lonsdale DO, Udy AA, Roberts JA, Lipman J (2013) Antibacterial therapeutic drug monitoring in cerebrospinal fluid: difficulty in achieving adequate drug concentrations. J Neurosurg 118:297\u2013301. \n                    https:\/\/doi.org\/10.3171\/2012.10.Jns12883","journal-title":"J Neurosurg"},{"key":"3680_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ijantimicag.2007.12.009","volume":"31","author":"PS McKinnon","year":"2008","unstructured":"McKinnon PS, Paladino JA, Schentag JJ (2008) Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents 31:345\u2013351. \n                    https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.12.009","journal-title":"Int J Antimicrob Agents"},{"key":"3680_CR16","doi-asserted-by":"publisher","first-page":"812.e811","DOI":"10.1016\/j.wneu.2016.12.076","volume":"99","author":"R Mounier","year":"2017","unstructured":"Mounier R, Lobo D, Hulin A, Nebbad B, Cook F, Dhonneur G (2017) Is first-line vancomycin still the best option to treat Staphylococcus health care-associated meningitis? World Neurosurg 99:812.e811\u2013812.e815. \n                    https:\/\/doi.org\/10.1016\/j.wneu.2016.12.076","journal-title":"World Neurosurg"},{"key":"3680_CR17","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/cmr.00007-10","volume":"23","author":"R Nau","year":"2010","unstructured":"Nau R, Sorgel F, Eiffert H (2010) Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 23:858\u2013883. \n                    https:\/\/doi.org\/10.1128\/cmr.00007-10","journal-title":"Clin Microbiol Rev"},{"key":"3680_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/02688690042834","volume":"14","author":"No Authors","year":"2000","unstructured":"No Authors (2000) The management of neurosurgical patients with postoperative bacterial or aseptic meningitis or external ventricular drain-associated ventriculitis. Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy. Br J Neurosurg 14:7\u201312","journal-title":"Br J Neurosurg"},{"key":"3680_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11096-006-9037-3","volume":"28","author":"M Pujal","year":"2006","unstructured":"Pujal M, Soy D, Codina C, Ribas J (2006) Are higher vancomycin doses needed in ventricle-external shunted patients? Pharm World Sci 28:215\u2013221. \n                    https:\/\/doi.org\/10.1007\/s11096-006-9037-3","journal-title":"Pharm World Sci"},{"key":"3680_CR20","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/CCM.0b013e3181961bff","volume":"37","author":"JA Roberts","year":"2009","unstructured":"Roberts JA, Lipman J (2009) Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 37:840\u2013851","journal-title":"Crit Care Med"},{"key":"3680_CR21","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/cid\/ciu027","volume":"58","author":"JA Roberts","year":"2014","unstructured":"Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J (2014) DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58:1072\u20131083. \n                    https:\/\/doi.org\/10.1093\/cid\/ciu027","journal-title":"Clin Infect Dis"},{"key":"3680_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1164\/rccm.201601-0024OC","volume":"194","author":"JA Roberts","year":"2016","unstructured":"Roberts JA, Abdul-Aziz MH, Davis JS, Dulhunty JM, Cotta MO, Myburgh J, Bellomo R, Lipman J (2016) Continuous versus intermittent beta-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials. Am J Respir Crit Care Med 194:681\u2013691. \n                    https:\/\/doi.org\/10.1164\/rccm.201601-0024OC","journal-title":"Am J Respir Crit Care Med"},{"key":"3680_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2146\/ajhp080434","volume":"66","author":"M Rybak","year":"2009","unstructured":"Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, Dalovisio JR, Levine DP (2009) Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 66:82\u201398. \n                    https:\/\/doi.org\/10.2146\/ajhp080434","journal-title":"Am J Health Syst Pharm"},{"key":"3680_CR24","doi-asserted-by":"publisher","unstructured":"Shah SS, Ohlsson A, Shah VS (2012) Intraventricular antibiotics for bacterial meningitis in neonates. Cochrane Database Syst Rev:Cd004496. \n                    https:\/\/doi.org\/10.1002\/14651858.CD004496.pub3","DOI":"10.1002\/14651858.CD004496.pub3"},{"issue":"6","key":"3680_CR25","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/cid\/ciy189","volume":"67","author":"Keaton S Smetana","year":"2018","unstructured":"Smetana KS, Cook AM (2018) Cerebrospinal fluid vancomycin dosing and monitoring: the quandary posed by guideline recommendations. Clin Infect Dis. \n                    https:\/\/doi.org\/10.1093\/cid\/ciy189","journal-title":"Clinical Infectious Diseases"},{"key":"3680_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00063-016-0185-5","volume":"112","author":"F Sorgel","year":"2017","unstructured":"Sorgel F, Hohl R, Glaser R, Stelzer C, Munz M, Vormittag M, Kinzig M, Bulitta J, Landersdorfer C, Junger A, Christ M, Wilhelm M, Holzgrabe U (2017) Pharmacokinetics and pharmacodynamics of antibiotics in intensive care. Med Klin Intensivmed Notfmed 112:11\u201323. \n                    https:\/\/doi.org\/10.1007\/s00063-016-0185-5","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"3680_CR27","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/cid\/cir197","volume":"52","author":"T Tangden","year":"2011","unstructured":"Tangden T, Enblad P, Ullberg M, Sjolin J (2011) Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases. Clin Infect Dis 52:1310\u20131316. \n                    https:\/\/doi.org\/10.1093\/cid\/cir197","journal-title":"Clin Infect Dis"},{"key":"3680_CR28","unstructured":"Testing ECoAS (2018) Clinical breakpoints - bacteria (v8.1). \n                    http:\/\/www.eucast.org\/clinical_breakpoints\/\n                    \n                  . Accessed June 7, 2018"},{"issue":"6","key":"3680_CR29","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1093\/cid\/ciw861","volume":"64","author":"Allan R. Tunkel","year":"2017","unstructured":"Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Michael Scheld W, van de Beek D, Bleck TP, Garton HJ, Zunt JR (2017) 2017 Infectious Diseases Society of America\u2019s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. \n                    https:\/\/doi.org\/10.1093\/cid\/ciw861","journal-title":"Clinical Infectious Diseases"},{"key":"3680_CR30","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJMra0804573","volume":"362","author":"D Beek van de","year":"2010","unstructured":"van de Beek D, Drake JM, Tunkel AR (2010) Nosocomial bacterial meningitis. N Engl J Med 362:146\u2013154. \n                    https:\/\/doi.org\/10.1056\/NEJMra0804573","journal-title":"N Engl J Med"},{"key":"3680_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jmii.2012.08.028","volume":"47","author":"JH Wang","year":"2014","unstructured":"Wang JH, Lin PC, Chou CH, Ho CM, Lin KH, Tsai CT, Wang JH, Chi CY, Ho MW (2014) Intraventricular antimicrobial therapy in postneurosurgical gram-negative bacillary meningitis or ventriculitis: a hospital-based retrospective study. J Microbiol Immunol Infect 47:204\u2013210. \n                    https:\/\/doi.org\/10.1016\/j.jmii.2012.08.028","journal-title":"J Microbiol Immunol Infect"},{"key":"3680_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S1042-3680(18)30666-1","volume":"3","author":"DY Wen","year":"1992","unstructured":"Wen DY, Bottini AG, Hall WA, Haines SJ (1992) Infections in neurologic surgery. The intraventricular use of antibiotics. Neurosurg Clin N Am 3:343\u2013354","journal-title":"Neurosurg Clin N Am"},{"key":"3680_CR33","first-page":"2185","volume":"12","author":"M Wolff","year":"1983","unstructured":"Wolff M, Regnier B, Garaud JJ, Faurisson F (1983) Intracisternal concentrations of vancomycin and amikacin after lumbar injections. Presse Med 12:2185","journal-title":"Presse Med"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00701-018-3680-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-018-3680-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-018-3680-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T19:18:05Z","timestamp":1569007085000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00701-018-3680-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,21]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["3680"],"URL":"https:\/\/doi.org\/10.1007\/s00701-018-3680-z","relation":{},"ISSN":["0001-6268","0942-0940"],"issn-type":[{"value":"0001-6268","type":"print"},{"value":"0942-0940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,21]]},"assertion":[{"value":"7 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}